Showing results (371-380 of 439) with videos related to

Sort By:
Pageof 44
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2013
Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysisAndrew M Evens, Ranjana Advani, Oliver W Press, et al.
Blood Advances|November 14, 2022
A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCLHua-Jay J Cherng, Stefan K Alig, Yasuhiro Oki, et al.
JAMA Network Open|April 7, 2025
Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T TherapyJames P Long, Rishab Prakash, Paul Edelkamp, et al.
The Lancet. Haematology|March 31, 2022
Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort studyCarla Casulo, Melissa C Larson, Julianne J Lunde, et al.
American Journal of Hematology|June 4, 2026
Development and Validation of a Novel Conditional Event-Free Survival Tool in Diffuse Large B-Cell LymphomaZhengming Chen, Danny Luan, Rasmus Rask Kragh Jørgensen, et al.
Leukemia & Lymphoma|December 6, 2021
Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphomaAhmad S Halwani, Carlos Panizo, Iris Isufi, et al.
The New England Journal of Medicine|January 24, 2014
PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphomaAjay K Gopal, Brad S Kahl, Sven de Vos, et al.
Frontiers in Immunology|February 17, 2025
Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomasGohar S Manzar, Chelsea C Pinnix, Stephanie O Dudzinski, et al.
Blood|May 5, 2022
Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphomaHua-Jay J Cherng, Ryan Sun, Bryant Sugg, et al.
Hematological Oncology|October 7, 2025
Adaptation and Performance of the Self-Report-Generated Charlson Comorbidity Index in the Lymphoma Epidemiology of Outcomes (LEO) CohortJames R Cerhan, Tereza Sokolova, Elliott J Cahn, et al.
Pageof 44